3 US Growth Companies With Up To 28% Insider Ownership

After reaching record highs, U.S. stock markets recently experienced a pullback, with major indices like the S&P 500 and Nasdaq Composite seeing declines. Amidst these fluctuations, investors often seek out growth companies with substantial insider ownership as a potential indicator of strong alignment between company leadership and shareholders. In this environment, identifying such companies can be crucial for those looking to navigate market volatility effectively.

Top 10 Growth Companies With High Insider Ownership In The United States

Name	Insider Ownership	Earnings Growth
Atour Lifestyle Holdings (NasdaqGS:ATAT)	25.4%	25.6%
Super Micro Computer (NasdaqGS:SMCI)	14.4%	27.6%
On Holding (NYSE:ONON)	19.1%	30.2%
Astera Labs (NasdaqGS:ALAB)	15.7%	61.3%
Kingstone Companies (NasdaqCM:KINS)	20.8%	24.9%
Clene (NasdaqCM:CLNN)	21.6%	59.1%
BBB Foods (NYSE:TBBB)	16.5%	41.1%
Enovix (NasdaqGS:ENVX)	12.8%	56.0%
Upstart Holdings (NasdaqGS:UPST)	12.6%	103.4%
Credit Acceptance (NasdaqGS:CACC)	14.2%	33.6%

Click here to see the full list of 197 stocks from our Fast Growing US Companies With High Insider Ownership screener.

Let's uncover some gems from our specialized screener.

Bruker (NasdaqGS:BRKR)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Bruker Corporation, with a market cap of $7.81 billion, develops, manufactures, and distributes scientific instruments and analytical and diagnostic solutions across the United States, Europe, the Asia Pacific, and internationally.

Operations: The company's revenue segments include Bruker Nano at $1.10 billion, Bruker CALID at $1.09 billion, Bruker Biospin at $905.70 million, and Bruker Energy & Supercon Technologies (BEST) at $283 million.

Insider Ownership: 28.2%

Bruker Corporation, with substantial insider buying recently, is positioned for significant earnings growth at 61.3% annually, although revenue growth is slower than the market. Despite a drop in profit margins and net income from last year, analysts expect a stock price increase of 29.3%. The company launched innovative products like the LUMOS II ILIM microscope and Dimension Nexus AFM, enhancing its research capabilities in life sciences and pharmaceuticals.

• Dive into the specifics of Bruker here with our thorough growth forecast report.
• Our valuation report unveils the possibility Bruker's shares may be trading at a premium.

Super Micro Computer (NasdaqGS:SMCI)

Simply Wall St Growth Rating: ★★★★★★

Overview: Super Micro Computer, Inc. develops and manufactures high performance server and storage solutions based on modular and open architecture, serving markets in the United States, Europe, Asia, and internationally with a market cap of $35.28 billion.

Operations: The company's revenue segment includes the development and provision of high performance server solutions, generating $14.94 billion.

Insider Ownership: 14.4%

Super Micro Computer is poised for strong growth, with expected annual revenue and earnings increases of 29.1% and 27.6%, respectively, outpacing the broader US market. Despite recent volatility in its share price and delayed SEC filings, the company has expanded its AI data center solutions with NVIDIA Blackwell technology. The issuance of $700 million in convertible notes supports further expansion but comes amid revised fiscal year revenue guidance to $23.5 billion-$25 billion from prior estimates.

• Unlock comprehensive insights into our analysis of Super Micro Computer stock in this growth report.
• According our valuation report, there's an indication that Super Micro Computer's share price might be on the cheaper side.

Bausch Health Companies (NYSE:BHC)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Bausch Health Companies Inc. is a diversified specialty pharmaceutical and medical device company operating in the United States and internationally, with a market cap of approximately $2.39 billion.

Operations: The company's revenue is primarily derived from its specialty pharmaceuticals and medical devices operations across both domestic and international markets.

Insider Ownership: 10.5%

Bausch Health Companies has shown significant improvement, reporting a net income of US$93 million for Q4 2024, reversing a prior loss. While revenue growth is expected to decline slightly over the next three years, the company is forecast to achieve profitability above market average. The recent appointment of Jonathan Sadeh as Chief Medical Officer emphasizes its commitment to innovation and growth in R&D. Despite negative shareholder equity, it trades at good value compared to peers.

• Click here to discover the nuances of Bausch Health Companies with our detailed analytical future growth report.
• Our expertly prepared valuation report Bausch Health Companies implies its share price may be lower than expected.

Turning Ideas Into Actions

• Access the full spectrum of 197 Fast Growing US Companies With High Insider Ownership by clicking on this link.
• Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Seeking Other Investments?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com